Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Venditti, Carolina C ^a   Casselman, Richard ^a   Young, Iain ^a   Karumanchi, S Ananth ^c   Smith, Graeme N ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FETUS RESORPTION; FETUS WEIGHT; LITTER SIZE; LOW DRUG DOSE; MATERNAL HYPERTENSION; MOUSE; NONHUMAN; PLACENTA WEIGHT; PREECLAMPSIA; PROTEINURIA; ADENOVIRIDAE; ANIMAL; BLOOD; COMPLICATION; DISEASE MODEL; GENETICS; HYPERTENSION; MOTHER; PREGNANCY; VIROLOGY;

ADENOVIRIDAE; ANIMALS; CARBON MONOXIDE; DISEASE MODELS, ANIMAL; FEMALE; HYPERTENSION; MICE; MOTHERS; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84928403856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106502     Document Type: Article

References (44)

1. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365: 785-799.
2. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA (2002) Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9: 147-160.
3. Cockell AP, Learmont JG, Smarason AK, Redman CW, Sargent IL, et al. (1997) Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. BJOG: Int J Gynaecol Obstet 104: 235-240.
4. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, et al. (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161: 1200-1204.
5. Lam C, Lim KH, Karumanchi SA (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertens 46: 1077-1085.
6. Shibuya M (2006) Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt- 1): a dual regulator for angiogenesis. Angiogen 9: 225-230.
7. Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658. 10.1172/JCI17189 [doi].
8. Vuorela P, Helske S, Hornig C, Alitalo K, Weich H, et al. (2000) Amniotic fluidsoluble vascular endothelial growth factor receptor-1 in preeclampsia. Obstet Gynecol 95: 353.
9. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. New Eng J of Med 350: 672-683.
10. Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, et al. (2007) The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol 196: 396-3e1.
11. Suzuki H, Ohkuchi A, Matsubara S, Takei Y, Murakami M, et al. (2009) Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertens 54: 1129-1135.
12. Bergmann A, Ahmad S, Cudmore M, Gruber AD, Wittschen P, et al. (2010) Reduction of circulating soluble Flt 1 alleviates preeclampsia like symptoms in a mouse model. J of Cell & Mol Med 14: 1857-1867.
13. England L, Zhang J (2007) Smoking and risk of preeclampsia: a systematic review. Front Biosci 12: 2471-2483.
14. Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC (1999) Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol 181: 1026-1035.
15. Wikstrom AK, Stephansson O, Cnattingius S (2010) Tobacco Use During Pregnancy and Preeclampsia Risk. Hypertens 55: 1254-1259.
16. England LJ, Levine RJ, Mills JL, Klebanoff MA, Yu KF, et al. (2003) Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol 189: 939-943.
17. Bainbridge SA, Sidle EH, Smith GN (2005) Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypoth 64: 17-27.
18. Kreiser D, Baum M, Seidman DS, Fanaroff A, Shah D, et al. (2004) End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia. J Perinat 24: 213-217.
19. Zhai D, Guo Y, Smith G, Krewski D, Walker M, et al. (2012) Maternal exposure to moderate ambient carbon monoxide is associated with decreased risk of preeclampsia. Am J Obstet Gynecol 207: 57-59. S0002-9378(12)00322-5 [pii]; 10.1016/j.ajog.2012.03.022 [doi].
20. Bainbridge SA, Belkacemi L, Dickinson M, Graham CH, Smith GN (2006) Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast. Am J Path 169: 774.
21. Bainbridge SA, Farley AE, McLaughlin BE, Graham CH, Marks GS, et al. (2002) Carbon monoxide decreases perfusion pressure in isolated human placenta. Placenta 23: 563-569.
22. Venditti CC, Casselman R, Smith GN (2011) Effects of chronic carbon monoxide exposure on fetal growth and development in mice. BMC Preg Childb 11: 101.
23. Venditti CC, Casselman R, Murphy MS, Adamson SL, Sled JG, et al. (2013) Chronic carbon monoxide inhalation during pregnancy augments uterine artery blood flow and uteroplacental vascular growth in mice. Am J Physiology Regul Integr Comp Physiol 305: R939-R948.
24. Mateus J, Bytautiene E, Lu F, Tamayo EH, Betancourt A, et al. (2011) Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1. Am J Physiol Heart Circ Physiol 301: H1781-H1787.
25. Li Z, Zhang Y, Ying Ma J, Kapoun AM, Shao Q, et al. (2007) Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertens 50: 686-692.
26. Graham FL, Van der Eb AJ (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virol J 52: 456-467.
27. George EM, Arany M, Cockrell K, Storm MV, Stec DE, et al. (2011) Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats. Am J Physiology Regul Integr Comp Physiol 301: R1495-R1500.
28. Neuzil J, Stocker R (1993) Bilirubin attenuates radical-mediated damage to serum albumin. FEBS letters 331: 281-284.
29. Bainbridge SA, Smith GN (2005) HO in pregnancy. Free Radic Biol Med 38: 979-988. S0891-5849(04)00892-5 [pii];10.1016/j.freeradbiomed.2004.11.002 [doi].
30. Wu L, Wang R (2005) Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57: 585-630.
31. George EM, Colson D, Dixon J, Palei AC, Granger JP (2011) Heme Oxygenase- 1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin. Int J Hypertens 2012.
32. Botros T, Schwartzman ML, Stier T, Goodman AI, Abraham NG (2005) Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidn Int 68: 2745-2755.
33. Cao J, Inoue K, Li X, Drummond G, Abraham NG (2009) Physiological significance of heme oxygenase in hypertension. Int J Biochem Cell Bio 41: 1025-1033.
34. Sabaawy HE, Zhang F, Nguyen X, ElHosseiny A, Nasjletti A, et al. (2001) Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertens 38: 210-215.
35. Yang L, Quan S, Nasjletti A, Laniado-Schwartzman M, Abraham NG (2004) Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure. Hypertens 43: 1221-1226.
36. Maines MD (1997) The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554.
37. Hayman R, Brockelsby J, Kenny L, Baker P (1999) Preeclampsia: the endothelium, circulating factor (s) and vascular endothelial growth factor. J Soc Gynecol Invest 6: 3.
38. Spargo B, McCartney CP, Winemiller R (1959) Glomerular capillary endotheliosis in toxemia of pregnancy. Arch Pathol 68: 593.
39. Orsolic- N, Sirovina D, Kon-ìi-ç MZ, Lackovi-ç G, Gregorovi-ç G (2012) Effect of Croatian propolis on diabetic nephropathy and liver toxicity in mice. BMC Complemen Altern Med 12: 117.
40. Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease podocyte injury comes of age in diabetic nephropathy. Diabetes 54: 1626-1634.
41. Farina A, Sekizawa A, De Sanctis P, Purwosunu Y, Okai T, et al. (2008) Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. Prenat Diagn 28: 956-961.
42. Baum M, Schiff E, Kreiser D, Dennery P, Stevenson DK, et al. (2000) End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol 183: 900-903. S0002-9378 (00)81205-3 [pii];10.1067/mob.2000.109047 [doi].
43. Sollwedel A, Bertoja AZ, Zenclussen ML, Gerlof K, Lisewski U, et al. (2005) Protection from abortion by heme oxygenase-1 up-regulation is associated with increased levels of Bag-1 and neuropilin-1 at the fetal-maternal interface. J Immunol 175: 4875-4885.
44. El-Mousleh T, Casalis PA, Wollenberg I, Zenclussen ML, Volk HD, et al. (2012) Exploring the potential of low doses carbon monoxide as therapy in pregnancy complications. Med Gas Res 2: 4.